This idea is further supported by a recent assessment of ALK TKI-associated cardiotoxicity revealing that, in addition to the physiological burdens of cancer, old age and decreased cardiac function further increase the risk for drug-induced cardiac disorders [81]. This evidence concerns the gene ALK and cancer.